Hot Water Immersion After Myocardial Infarction

Status Recruiting

Clinical Trial Summary

Myocardial infarction (MI) is a leading cause of death in developed countries, including Sweden. Standard treatment for patients after MI includes exercise-based cardiac rehabilitation which contributes to improved cardiovascular function and reduces the risk of hospital readmissions, new cardiovascular events and mortality. Thermotherapy may also have beneficial effects on cardiovascular disease by a reduction in inflammatory status and improved metabolism and vascular function. Given the well-documented effects of exercise training on cardiac rehabilitation and recent evidence that thermotherapy may improve cardiovascular function, we wish to investigate the effect of exercise combined with hot water immersion (HWI) in cardiac rehabilitation post-MI. This is a single-centre, randomized controlled clinical trial in patients with recent MI. Our aim is to investigate whether exercise training combined with HWI improves inflammatory and metabolic status, cardiovascular function as well as psychological well-being, compared with exercise training alone. Patients will be randomized 1:1 to an 8 week intervention with exercise training 2 times per week followed by 15 minutes of hot water immersion, or to a control group with exercise training alone. The primary endpoint is changes in the inflammatory marker interleukin (IL-) 6 between groups at 8 weeks. Secondary endpoints include other biomarkers of inflammation, metabolism, effects on cardiovascular function and psychological benefits. Secondary prevention after MI has improved during the last decades but readmissions and death following acute MI remain large health challenges. If HWI in addition to standard cardiac rehabilitation can lower inflammation more than standard therapy alone, and improve metabolic, cardiovascular and psychological status, it could be a cost-effective and safe complementary strategy for secondary prevention after MI, particularly for those with limited exercise capability.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05725655
Study type	Interventional
Source	Region Örebro County
Contact	Ole Fröbert, Professor
Phone	+460196025413
Email	ole.frobert@regionorebrolan.se
Status	Recruiting
Phase	N/A
Start date	October 26, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05490303` - HeartGuide: Preliminary Study	N/A
Completed	`NCT05070819` - Atrial Natriuretic Peptide in Assessing Fluid Status	N/A
Not yet recruiting	`NCT04538469` - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting	`NCT04511403` - Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
Completed	`NCT02697760` - The CZT Dynamic Myocardial Perfusion Imaging
Terminated	`NCT05157568` - Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation	N/A
Not yet recruiting	`NCT04160845` - Non-invasive Forehead Skin Temperature in Cardiac Surgery
Completed	`NCT04500912` - Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population	N/A
Not yet recruiting	`NCT06438159` - Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.	N/A
Recruiting	`NCT06154473` - Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Not yet recruiting	`NCT05877755` - Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging	N/A
Completed	`NCT03394859` - Electronic Medical Records and Genomics (eMERGE) Phase III
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT04374799` - Heparin vs Placebo for Cardiac Catheterization	Phase 3
Completed	`NCT03174106` - Longterm Follow-up of Cardiac Patients With an Smartphone-Application	N/A
Recruiting	`NCT05531253` - Respired Gases in Patients Post Cardiac Surgery
Recruiting	`NCT04609228` - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
Recruiting	`NCT06149143` - Cardiac Performance System Data Collection Study - Minnesota
Recruiting	`NCT06073509` - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Enrolling by invitation	`NCT04886934` - Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hot Water Immersion After Myocardial Infarction — HOT-MI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms